Kunming Longjin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 406.39 K

Kunming Longjin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities is USD 406.39 K for the year ending December 31, 2023, a 122.40% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Kunming Longjin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -1.81 M, a -151.39% change year over year.
  • Kunming Longjin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 3.53 M, a -25.81% change year over year.
  • Kunming Longjin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 4.76 M, a 38.65% change year over year.
  • Kunming Longjin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 3.43 M, a 296.46% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
Shenzhen Stock Exchange: 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd.

CEO Mr. Ya He Li
IPO Date March 24, 2015
Location China
Headquarters NO.789, Lanmao Road
Employees 285
Sector Health Care
Industries
Description

Kunmig Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. The company offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; immune system and first aid medications; and vitamins, minerals, and enteral and parenteral nutrition products. It also engages in the industrial hemp plantation business. The company was founded in 1996 and is headquartered in Kunming, China.

Similar companies

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 2.18

1.66%

002728.SZ

Teyi Pharmaceutical Group Co.,Ltd

USD 1.16

3.79%

002737.SZ

Sunflower Pharmaceutical Group Co.,Ltd

USD 2.72

2.05%

002349.SZ

Jinghua Pharmaceutical Group Co., Ltd.

USD 1.01

2.22%

StockViz Staff

January 15, 2025

Any question? Send us an email